CSTL: Castle Biosciences, Inc. Company Total Revenue

castlebiosciences.com - graphic logo of issuer CSTL

Castle Biosciences demonstrates high macro resilience due to insurance coverage for its tests, which eliminates seasonality. This chart in the GURU.Markets interface displays the company's sales financial results, where the 0.38 level represents the current value. Growth is supported by close collaboration with oncologists and the effective commercialization of products under stable management.

Castle Biosciences (CSTL) Revenue and Sales Volume: for the period 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Castle Biosciences, Inc. (CSTL)

- stock quotes and analyst forecast:
Price Chart Castle Bio|CSTL - Consensus Target
- market capitalization information:
Market Value Castle Biosciences, Inc.|CSTL - Total Company Value
- book value of equity indicators:
Net Assets per Share Castle Biosciences|CSTL - Book Capitalization|Market Capitalization to Book Value castlebiosciences.com|CSTL - Aggregate Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Castle Biosciences|CSTL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Castle Biosciences Inc|CSTL - Company Aggregate Debts|Debts to Book Capitalization Castle Biosciences, Inc.|CSTL - Company Long-Term Debt|Short-Term Debt Volume Castle Biosciences|Intermediate Liquidity Ratio castlebiosciences.com
- earnings and market multiples details:
CSTL - Company Net Income|Expected Profit Castle Biosciences|CSTL - P/E Multiple|Projected Price to Earnings Ratio castlebiosciences.com|CSTL - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Castle Biosciences, Inc.|CSTL - Operating profit EBITDA|Earnings per share for the last twelve months Castle Biosciences|CSTL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months castlebiosciences.com|CSTL - Earnings per share growth in current year|Expected net earnings per share growth next year Castle Biosciences
- company sales and revenue statistics:
CSTL - Company Revenue|Company Future Sales Castle Bio|CSTL - P/S Multiple|Forward Price-to-Revenue Multiple Castle Biosciences, Inc.
Summary company analysis:CSTL, Castle Bio
Manufactured product of Castle Biosciences Corp

Castle Biosciences dominates the skin oncology diagnostics niche through its unique patented tests. Revenue measures the total volume of services rendered, reflecting the efficiency of its intellectual property monetization. Investors must compare sales growth rates with the share price to identify any overvaluation of the asset. The risk of capital drawdown is minimized once a sustainable expansion of market share is confirmed. This product sales trend confirms the fundamental resilience of the business.

Analysis of competing companies

Company Revenue CAI|Company Sales GH (Guardant Health, Inc.)|VCYT - Company Total Revenue|Company Revenue Celcuity CELC|Company Gross Revenue GRAIL Inc (GRAL)|Myriad Genetics Corp - Revenue and Sales Volume|Company Gross Revenue Burning Rock Biotech Ltd BNR|volition.com (VNRX) - Company Revenue|BDSX - Company Gross Revenue|PRPO (Precipio) - Revenue and Sales Volume|Company Sales Check-Cap Medical (CHEK)|Revenue and Sales Volume MYNZ|Revenue and Sales Volume OncoCyte Inc (OCX)